Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
BCRX Stock News and Mentions of BioCryst Pharmaceuticals, Inc. Stocktwits
Updated: April 28, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where BioCryst Pharmaceuticals Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of BioCryst Pharmaceuticals, Inc. (BCRX).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the BioCryst Pharmaceuticals stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of BioCryst Pharmaceuticals, Inc. (BCRX)
April 22, 2024 (11:00) / "Benzinga" (by Globe Newswire)
BioCryst to Report First Quarter 2024 Financial Results on May 6 - BioCryst Pharma ( NASDAQ:BCRX )
RESEARCH TRIANGLE PARK, N.C., April 22, 2024 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. BCRX today announced that the company will report its first quarter 2024 financial results on Monday, May 6, 2024. BioCryst management will host a conference call and webcast at 8:30 a.m.
In Article Trend: Somewhat-Bullish
April 22, 2024 (11:00) / "GlobeNewswire" (by BioCryst Pharmaceuticals)
BioCryst to Report First Quarter 2024 Financial Results on May 6
RESEARCH TRIANGLE PARK, N.C., April 22, 2024 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq: BCRX ) today announced that the company will report its first quarter 2024 financial results on Monday, May 6, 2024.
In Article Trend: Somewhat-Bullish
April 17, 2024 (08:30) / "Benzinga" (by Globe Newswire)
BioCryst Announces Approval of ORLADEYO® ( berotralstat ) by the Brazilian Health Regulatory Agency - BioCryst Pharma ( NASDAQ:BCRX )
RESEARCH TRIANGLE PARK, N.C., April 17, 2024 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. BCRX today announced that the Brazilian Health Regulatory Agency ( ANVISA ) has granted approval for oral, once-daily ORLADEYO® ( berotralstat ) for the prophylaxis of hereditary angioedema ( HAE ) ...
In Article Trend: Neutral
April 17, 2024 (08:30) / "GlobeNewswire" (by BioCryst Pharmaceuticals)
BioCryst Announces Approval of ORLADEYO® ( berotralstat ) by the Brazilian Health Regulatory Agency
RESEARCH TRIANGLE PARK, N.C., April 17, 2024 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq: BCRX ) today announced that the Brazilian Health Regulatory Agency ( ANVISA ) has granted approval for oral, once-daily ORLADEYO® ( berotralstat ) for the prophylaxis of hereditary ...
In Article Trend: Neutral
April 3, 2024 (11:00) / "GlobeNewswire" (by Inc.)
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
RESEARCH TRIANGLE PARK, N.C., April 03, 2024 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq: BCRX ) today announced that the compensation committee of BioCryst's board of directors granted six newly-hired employees stock options to purchase an aggregate of 43,975 shares, and ...
In Article Trend: Somewhat-Bullish
March 5, 2024 (12:01) / "GlobeNewswire" (by BioCryst Pharmaceuticals)
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
RESEARCH TRIANGLE PARK, N.C., March 05, 2024 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. ( Nasdaq: BCRX ) today announced that the compensation committee of BioCryst's board of directors granted three newly-hired employees stock options to purchase an aggregate of 16,050 shares, and ...
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
Schrodinger, Inc. (SDGR)
electroCore, Inc. (ECOR)
Incyte Corp. (INCY)
BridgeBio Pharma, Inc. (BBIO)
Virios Therapeutics, Inc. (VIRI)
Waters Corp. (WAT)
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
Alpine Immune Sciences, Inc. (ALPN)
Turning Point Therapeutics, Inc. (TPTX)
BiondVax Pharmaceuticals Ltd. (BVXV)
This website uses cookies to ensure you get the best experience on our website